Abstract
Molecular hybridization approach is a powerful medicinal chemistry tool for designing ligands and prototypes able to act in at least two different molecular targets, promoting a beneficial effect to the treatment of multifactorial diseases. In this context, this review describes some examples where the use of this molecular modification approach lead to the design of novel chemotherapy prototypes able to act simultaneously in more than one target enzyme useful to control diseases promoted by bacterial, viral, protozal or fungal pathogens.
Keywords: Molecular hybridization, chemotherapy, drug resistance, chemotherapeutic agents, hybrid therapy, biomacromolecule, drug-drug interactions, HYBRID ANTIBACTERIAL PROTOTYPES, aminoglycosides, enzymatic modification, antibiotics
Current Enzyme Inhibition
Title: Discovery of Dual Chemotherapy Drug Candidates Designed by Molecular Hybridization
Volume: 6 Issue: 4
Author(s): Rodolfo do Couto Maia and Carlos Alberto Manssour Fraga
Affiliation:
Keywords: Molecular hybridization, chemotherapy, drug resistance, chemotherapeutic agents, hybrid therapy, biomacromolecule, drug-drug interactions, HYBRID ANTIBACTERIAL PROTOTYPES, aminoglycosides, enzymatic modification, antibiotics
Abstract: Molecular hybridization approach is a powerful medicinal chemistry tool for designing ligands and prototypes able to act in at least two different molecular targets, promoting a beneficial effect to the treatment of multifactorial diseases. In this context, this review describes some examples where the use of this molecular modification approach lead to the design of novel chemotherapy prototypes able to act simultaneously in more than one target enzyme useful to control diseases promoted by bacterial, viral, protozal or fungal pathogens.
Export Options
About this article
Cite this article as:
do Couto Maia Rodolfo and Alberto Manssour Fraga Carlos, Discovery of Dual Chemotherapy Drug Candidates Designed by Molecular Hybridization, Current Enzyme Inhibition 2010; 6 (4) . https://dx.doi.org/10.2174/157340810794578515
DOI https://dx.doi.org/10.2174/157340810794578515 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
MDM2-p53 Interaction Inhibitors: The Current State-of-Art and Updated Patent Review (2010-Present)
Recent Patents on Anti-Cancer Drug Discovery 1,2,4-Triazine Chemistry Part III: Synthetic Strategies to Functionalized Bridgehead Nitrogen Heteroannulated 1,2,4-Triazine Systems and their Regiospecific and Pharmacological Properties
Current Organic Synthesis Immunotherapy of Kidney Cancer
Current Clinical Pharmacology Curcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications
Current Medicinal Chemistry Therapeutic Cancer Vaccines
Current Cancer Therapy Reviews Is 5-ASA Still the Treatment of Choice for Ulcerative Colitis?
Current Drug Targets Hairy Roots, their Multiple Applications and Recent Patents
Recent Patents on Biotechnology Inhibitory Effects of Caffeic Acid Ester Analogues on Free Radicals and Human Liver Microsome CYP1A2 Activities
Medicinal Chemistry Positron Emission Tomography: Applications In Drug Discovery and Drug Development
Current Topics in Medicinal Chemistry MiR 221/222 as New Players in Tamoxifen Resistance
Current Pharmaceutical Design Editorial (Thematic Issue: Perspectives on Strategies for Overcoming Cancer Therapy Resistance)
Current Protein & Peptide Science Radiotherapy Planning and Molecular Imaging in Lung Cancer
Current Radiopharmaceuticals Innovative Cancer Treatments that Augment Radiotherapy or Chemotherapy by the Use of Immunotherapy or Gene Therapy
Recent Patents on Anti-Cancer Drug Discovery Culture Supernatants from Lactobacillus plantarum Induce Necrosis on a Human Promyelocytic Leukemia Cell Line
Endocrine, Metabolic & Immune Disorders - Drug Targets Carotenoids as Modulators of Intracellular Signaling Pathways
Current Signal Transduction Therapy Ultrasound Assisted Synthesis of 3,4-Diyne Substituted Isocoumarin Derivatives: Identification of Potential Cytotoxic Agents
Mini-Reviews in Medicinal Chemistry Recent Patents on the Use of Antioxidant Agents in Food
Recent Patents on Food, Nutrition & Agriculture Oncogene Suppression by Small Interfering RNAs
Current Pharmaceutical Biotechnology Editorial [Hot Topic: Applications of Graph Theory, Network Theory, and Chemotopology to Structure-Activity Relationships and Characterization of Metabolic Processes (Guest Editors: Subhash C. Basak and Guillermo Restrepo)]
Current Computer-Aided Drug Design In Silico Study of Desmosdumotin as an Anticancer Agent: Homology Modeling, Docking and Molecular Dynamics Simulation Approach
Anti-Cancer Agents in Medicinal Chemistry